One of the major success stories in the spine arena of the last decade, XLIF is a less invasive way to approach spinal fusion surgery. XLIF spinal fusion is performed from the side rather than the front or back, dramatically reducing pain and recovery time. NuVasive engaged The Ruth Group to build visibility for its innovative spine technology.
The TRG “Cheetah” Speed Match
Delivering the Deliverables
Our Commitment Never Ceases
The process of moving drug candidates through Phase 3 clinical development and to regulatory review faces significant challenges. The hurdles are higher than ever, and the effective communication of clinical and regulatory milestones is critical. NeurogesX is a standout for success in developing and commercializing a novel treatment for neuropathic pain.
Creating a New Treatment Paradigm
IPC The Hospitalist Company, Inc.
IPC created a new medical paradigm with the formation of the first major player in the hospitalist sector. New paradigms require education and clear messaging. TRG made that happen with its IPO in 2008 and continues to on a regular basis. The value of the Company today reflects the continuing success of its business model and the efficiency it offers to the healthcare system.
A Rapid Growth Story, Under the Radar
A True IR Partner
A Sure Model for Success
Leveraging Scientific Milestones for Visibility
A Strong Drive for Positioning and Credibility
The Results Continue